Background and Purpose-No standard approach to obtaining informed consent for stroke thrombolysis with tPA (tissuetype plasminogen activator) currently exists. We aimed to assess current nationwide practice patterns of obtaining informed consent for tPA. Methods-An online survey was developed and distributed by e-mail to clinicians involved in acute stroke care. Multivariable logistic regression analyses were performed to determine independent factors contributing to always obtaining informed consent for tPA. Results-Among 268 respondents, 36.7% reported always obtaining informed consent and 51.8% reported the informed consent process caused treatment delays. Being an emergency medicine physician (odds ratio, 5.8; 95% confidence interval, 2.9-11.5) and practicing at a nonacademic medical center (odds ratio, 2.1; 95% confidence interval, 1.0-4.3) were independently associated with always requiring informed consent. The most commonly cited cause of delay was waiting for a patient's family to reach consensus about treatment. 
T he benefits of tPA (tissue-type plasminogen activator) for acute ischemic stroke are extremely time dependent. 1 Efforts such as the American Heart Association's Get With The Guidelines-Stroke focusing on systems-based improvements have reduced thrombolytic treatment times nationally. 2 Despite this and similar initiatives, substantial proportions of tPA-eligible patients still have delayed treatment, 2 although some refuse tPA treatment altogether. 3 Current professional guidelines recommend that physicians obtain informed consent before the administration of tPA. 4, 5 Improvement in the informed consent process has been a suggested target to further reduce delays. 3, 6 However, no standardized approach exists to obtain informed consent for tPA. The objective of this national survey was to determine current practice patterns of informed consent for stroke thrombolysis.
Methods
All data, analytic methods, and study materials are available on request. See the Methods section in the online-only Data Supplement for complete details.
Survey Content
We developed a 27-question survey assessing practice patterns of obtaining informed consent for tPA. Informed consent was defined as either written or verbal informed consent. Respondents were asked but not required to add free-text responses describing the causes of delay in obtaining informed consent.
Survey Administration and Participant Selection
Invitations to participate in the online survey were emailed to clinicians (eg, neurologists, emergency physicians, interventional radiologists, and internists). The survey was self-administered and remained open from November 1, 2015 , until February 29, 2016 . We used a modified Dillman recruitment method to increase participation. 7 Consent was provided on initiation of the survey. The local Institutional Review Board approved the study.
Data Analysis
Descriptive statistics entailed χ 2 tests for categorical comparisons and nonparametric tests for continuous variables. Multivariable logistic regression analyses were performed to determine independent factors contributing to consent practices.
Qualitative analysis involved thematic analysis 8 of free-text comments that were independently coded by 2 authors (S.J.M. and L.F.T.). Coding continued until reaching thematic saturation. 
Results

Response Rate and Demographics
Of 809 invited clinicians, 268 (33.1%) completed the survey among whom 199 clinicians reported routinely evaluating acute stroke patients' eligibility for tPA ( Table 1) .
Practices of Informed Consent for tPA
Neurology attending physicians (64.8%), neurology residents (57.8%), and emergency medicine attending physicians (54.8%) were identified most often involved in obtaining informed consent (Table I in the online-only Data Supplement). Most respondents (90.5%) identified the risk of intracranial hemorrhage as necessary content to disclose and 87.4% reported a verbal description of risk and benefits as the preferred means of communication.
In the 3-hour treatment window, 36.7% of respondents reported always requiring informed consent (Table 2) , being highest among emergency medicine physicians. Another 21.1% of clinicians reported never requiring informed consent for tPA in the 3-hour window, being highest among those who practiced neurology (69.0%).
In the 3-to 4.5-hour treatment window, 50.3% of respondents indicated that they always obtain informed consent, including 8.0% who require signed written consent. Another 13.5% of clinicians reported never obtaining informed consent for tPA in the extended window.
Over half of clinicians (51.8%) reported a delay in administering tPA because of a problem in obtaining informed consent. The median frequency of consent-related delay was 15.0% (interquartile range, 10.0%-25.0%).
In univariable analysis, being an emergency medicine physician (P<0.01), practicing for >20 years (P=0.03), and not being affiliated with an academic medical center (P<0.01) were associated with always requiring informed consent for tPA within the 3-hour time window. In a multivariable model of predictors of always requiring consent, emergency medicine physicians (odds ratio, 5.8; 95% confidence interval, 2.9-11.5; P<0.01) and practicing at a nonacademic medical center (odds ratio, 2.1; 95% confidence interval, 1.0-4.3; P=0.04) were significantly more likely to always require consent for tPA. 
Causes for Delay
We identified 3 major themes from the 85 completed surveys (42.7%) that contained free-text comments about the causes for consent delay (Table II in the online-only Data Supplement). The most commonly cited theme (36.5%) was delay because of waiting for a patient's family to reach consensus about treatment.
Discussion
In a national survey, a majority of clinicians always or often require informed consent for tPA and report treatment delays because of the informed consent process. Because informed consent is a barrier to stroke thrombolysis, future interventions to facilitate rapid treatment should target consent practices. Current professional guidelines recommend obtaining informed consent for tPA when feasible, 4, 5 such as when the patient possesses capacity or a proxy can be found after reasonable effort. 4 Our finding that emergency medicine physicians are more likely to require informed consent may reflect different professional views about risks and benefits of tPA. The American Academy of Emergency Medicine states that objective evidence regarding efficacy, safety, and applicability of tPA for acute ischemic stroke is insufficient to warrant its classification as a standard of care. 9 This is in contrast to the American Academy of Neurology 10 and American Heart Association/ American Stroke Association's 5 strong endorsement. Although a variety of decision aids exist to assist clinicians in the informed consent process for tPA, 11, 12 no standardized content, format, nor requirements have been developed. A generalizable decision aid will need to balance the informational needs of patients and proxies with the time-sensitive nature of stroke thrombolysis.
This study has limitations. The response rate, although low for an in-person survey, is consistent with online surveys administered to healthcare professionals. 13 The findings may not generalize to all stroke providers. The results may overrepresent the practices of neurologists and those practicing in academic medical centers that comprised the majority of respondents. However, we included clinicians from academic, nonacademic, urban, and rural healthcare systems in 40 different states. Respondents' reported behaviors may not reflect actual behavior. Lastly, thematic analyses were limited to those clinicians who provided free-text comments and, thus, may not reflect all clinicians' experiences.
Summary
Most clinicians obtain informed consent before stroke thrombolysis and experience delays during the process. Emergency medicine physicians and those practicing at nonacademic medical centers are more likely to require consent for tPA. Given the time-sensitive nature of stroke thrombolysis, future research should focus on standardizing the content, format, and delivery of information in a manner that respects patient autonomy while delivering timely treatment.
Sources of Funding
This study was supported by the Institute of Medicine of Chicago/ Blue Cross Blue Shield of Illinois Health Disparities grant (Principal Investigator Dr Prabhakaran).
